INFASURF (Ony, Inc.)


Welcome to the PulseAid listing for the INFASURF drug offered from Ony, Inc.. This Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Ony, Inc.
NON-PROPRIETARY NAME: CALFACTANT
SUBSTANCE NAME: CALFACTANT
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA]
ROUTE: ENDOTRACHEAL
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-07-21
END MARKETING DATE: 0000-00-00


INFASURF HUMAN PRESCRIPTION DRUG Details:

Item DescriptionINFASURF from Ony, Inc.
LABELER NAME: Ony, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 35.7(mg/mL)
START MARKETING DATE: 2011-07-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61938-456_d37c02fb-1bed-4400-92d2-50a67e539beb
PRODUCT NDC: 61938-456
APPLICATION NUMBER: NDA020521

Other CALFACTANT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Ony, Inc.INFASURF